Revenue | ₹3,791.35Cr |
Net Profits | ₹511.51Cr |
Net Profit Margins | 13.49% |
Mankind Pharma Ltd’s revenue jumped 19.49% since last year same period to ₹3,791.35Cr in the Q2 2025-2026. On a quarterly growth basis, Mankind Pharma Ltd has generated 3.78% jump in its revenue since last 3-months.
Mankind Pharma Ltd’s net profit fell -21.72% since last year same period to ₹511.51Cr in the Q2 2025-2026. On a quarterly growth basis, Mankind Pharma Ltd has generated 16.7% jump in its net profits since last 3-months.
Mankind Pharma Ltd’s net profit margin fell -34.49% since last year same period to 13.49% in the Q2 2025-2026. On a quarterly growth basis, Mankind Pharma Ltd has generated 12.45% jumped in its net profit margins since last 3-months.
The revenue for Mankind Pharma Ltd in the Q2 results 2025 was ₹3,791.35Cr.
The net profit for Mankind Pharma Ltd in the Q2 results 2025 was ₹511.51Cr.
The net profit margin for Mankind Pharma Ltd in the Q2 results 2025 was 13.49%.
The revenue for Mankind Pharma Ltd in the Q2 results 2024 was ₹3,173.06Cr.
The net profit for Mankind Pharma Ltd in the Q2 results 2024 was ₹653.47Cr.
The net profit margin for Mankind Pharma Ltd in the Q2 results 2024 was 20.59%.